| |
|
|
| |
|
|
|
| Protein production and cGMP manufacturing |
|
Protein Production Services (PPS) is your partner for cGMP contract manufacturing services of monoclonal antibodies and other recombinant proteins for preclinical and Phase I/II clinical trials.
Our streamlined cGMP compliant technological platform offers a comprehensive package to our clients all the way from cloning to scale up and phase I and II bulk API.
|
|
|
|
|
| | |
| | | December 14, 2009 | | | | Protein Production Services Ltd. (PPS) announced today that the company had been awarded a second year grant from Israel's prestigious Office of the Chief Scientist (OCS) program of support for industrial R&D. The grant was designated by the OCS to partially fund the continuation of Factor VIIa process development and production program, as a part of the company's platform of "Biosimilars Plus". | | more | | | | September 1, 2009 | | | | PPS has entered into an agreement with BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, for cGMP production of BrainStorm's stem cell therapeutic product. The clinical-grade product will be used in a pre-clinical safety trial for the company’s innovative therapy for ALS.
| | more | | | | March 10. 2009 | | | | Seraffix started Phase I clinical trials that will include 15 patients. A clinical batch of the protein component for the trial was prepared and released by PPS. | | more | | | | February 10, 2009 | | | | PPS Participated in a business delegation to Thistle Bioscience Showcase Event in Edinburgh, Scotland on February 3-6 2009. The mission was organized by the UK Trade & Investment as part of its ongoing programme of developing links between the UK and Israel in the life sciences sector. | | more | | | | January 19, 2009 | | | | Dr. Eli Opper, Chief Scientist of the Ministry of Industry, Trade and Labor, visited PPS and was introduced to the company's facilities and services. | | more | | | | April 22, 2008 | | | | PhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration at BIO National Venture Conference 2008. The preclinical anti-cancer and ophthalmic experiments were performed using VEGFb produced by PPS. | | more | | |
|
